Projects per year
Fingerprint
Dive into the research topics where Hong Qin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Translation development of a novel therapeutic antibody against drug-resistant B-cell malignancies
Kwak, L. W. & Qin, H.
12/7/18 → 11/30/21
Project: Research project
-
Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies
Dong, Z., Song, J. Y., Thieme, E., Anderson, A., Oh, E., Cheng, W. A., Kuang, B. Z., Lee, V., Zhang, T., Wang, Z., Szymura, S., Smith, D. L., Zhang, J., Nian, W., Zheng, X., He, F., Zhou, Q., Cha, S. C., Danilov, A. V., Qin, H., & 1 others, Mar 28 2023, In: Blood Advances. 7, 6, p. 918-932 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
Wang, X., Dong, Z., Awuah, D., Chang, W. C., Cheng, W. A., Vyas, V., Cha, S. C., Anderson, A. J., Zhang, T., Wang, Z., Szymura, S. J., Kuang, B. Z., Clark, M. C., Aldoss, I., Forman, S. J., Kwak, L. W. & Qin, H., Apr 2022, In: Leukemia. 36, 4, p. 1015-1024 10 p.Research output: Contribution to journal › Article › peer-review
-
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells
Kharfan-Dabaja, M. A., Yassine, F., Gadd, M. E. & Qin, H., Jan 2022, In: Transplantation and Cellular Therapy. 28, 1, p. 5-17 13 p.Research output: Contribution to journal › Review article › peer-review
-
Genomic landscape of lung adenocarcinomas in different races
Shi, H., Seegobin, K., Heng, F., Zhou, K., Chen, R., Qin, H., Manochakian, R., Zhao, Y. & Lou, Y., Sep 28 2022, In: Frontiers in Oncology. 12, 946625.Research output: Contribution to journal › Article › peer-review
Open Access -
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Wen, T., Barham, W., Li, Y., Zhang, H., Gicobi, J. K., Hirdler, J. B., Liu, X., Ham, H., Peterson Martinez, K. E., Lucien, F., Lavoie, R. R., Li, H., Correia, C., Monie, D. D., An, Z., Harrington, S. M., Wu, X., Guo, R., Dronca, R. S., Mansfield, A. S., & 9 others, Feb 2022, In: Cancer Immunology Research. 10, 2, p. 162-181 20 p.Research output: Contribution to journal › Article › peer-review
Open Access